In committee
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
People affected—not yet estimated
Fiscal magnitude—not yet estimated
Reach—
How your members of Congress line up
How it moved.
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate